Pharmacology of 1-(p-chlorobenzenesulfonyl)-3-n-propylurea (Chlorpropamide)

Root, Mary A; Sigal, Max V; Anderson, R C

doi:10.2337/diab.8.1.7

Article navigation

Articles| January 01 1959

Pharmacology of 1-(p-chlorobenzenesulfonyl)-3-n-propylurea (Chlorpropamide)

Mary A Root, Ph.D;

Mary A Root, Ph.D

Lilly Research Laboratories, Eli Lilly and Company

Indianapolis, Indiana

Search for other works by this author on:

This Site

PubMed

Google Scholar

Max V Sigal, Jr, Ph.D;

Max V Sigal, Jr, Ph.D

Lilly Research Laboratories, Eli Lilly and Company

Indianapolis, Indiana

Search for other works by this author on:

This Site

PubMed

Google Scholar

R C Anderson, Sc.D

Lilly Research Laboratories, Eli Lilly and Company

Indianapolis, Indiana

Search for other works by this author on:

This Site

PubMed

Google Scholar

Diabetes 1959;8(1):7–13

https://doi.org/10.2337/diab.8.1.7

PubMed:

13619485

Pharmacology of 1-(p-chlorobenzenesulfonyl)-3-n-propylurea (Chlorpropamide)

Article PDF first page preview

Email alerts

Journals

Books

Clinical Compendia

News

Podcasts

Other

About

Resources

Pharmacology of 1-(p-chlorobenzenesulfonyl)-3-n-propylurea (Chlorpropamide)

Article PDF first page preview

Email alerts

Journals

Books

Clinical Compendia

News

Podcasts

Other

About

Resources

This Feature Is Available To Subscribers Only